StockpollyBeta
Get App
Popularity #1,241
IRON · NASDAQ · Biotechnology

Disc Medicine (IRON)

Develops heme and iron-homeostasis therapies for serious blood disorders.

$65.42
vs last close−3.06 (−4.47%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
193031313335406168677065
Research & development142324232525284650464647
5787810121517212418
General & administrative5787810121517212418
Operating income−19−30−31−31−33−35−40−61−68−67−70−65
565565665766
Interest income555566776777
Interest expense000000111111
Other non-operating income0−6−5−5−6−21−7−7−6−7−7−7
Income before tax−14−24−27−26−26−29−34−55−62−60−63−59
Income tax expense000000000000
Net income from continuing operations−14−24−27−26−27−29−34−55−62−61−64−60
Net income−14−24−27−26−27−29−34−55−62−61−64−60
EPS, basic−$0.58−$1.00−$1.09−$1.03−$0.89−$0.98−$1.02−$1.58−$1.77−$1.64−$1.65−$1.54
EPS, diluted−$0.58−$1.00−$1.09−$1.03−$0.89−$0.98−$1.02−$1.58−$1.77−$1.64−$1.65−$1.54
Weighted average shares, basic242425263030333535353839
Weighted average shares, diluted242425263030333535353839
EBITDA−19−24−27−26−26−13−33−54−61−59−63−58
Depreciation & amortization000000000000
EBIT−19−24−27−26−26−13−33−54−61−60−63−59